FDA CT overdose probe focuses on Cedars-Sinai

Oct 12, 2009

Cedars-Sinai Medical Center in Los Angeles is the focus of a U.S. Food and Drug Administration investigation into more than 200 cases of overexposure to radiation during CT brain perfusion studies.

Click here to read the rest of the article.

Latest in CT
Chatgpt Artificial Intelligence Ai Head n9f Ar0 G2 Ll
General-purpose LLMs can be used to track true critical findings
September 10, 2025
You think ahead. We innovate ahead.
Sponsored
You think ahead. We innovate ahead.
September 9, 2025
2025 09 09 Generalist Radiology Ai Six Diagnoses Thumbnail
Experts propose generalist radiology AI framework
September 9, 2025
Representative axial images of mild, moderate, and severe emphysema at baseline low-dose CT (LDCT). Participants were categorized as having no emphysema or mild, moderate, or severe emphysema. When present, emphysema was mild if no distinct regions of reduced attenuation were visible on the CT scan, but vascular splaying indicates parenchymal expansion, or if only occasional discrete low-attenuation regions were observed. Moderate emphysema was defined by the presence of identifiable low-attenuation regions affecting less than half of the lung parenchyma, whereas severe emphysema was defined by the presence of identifiable low-attenuation regions that involved more than half of the lung parenchyma. A scoring system from 0 to 3 was applied, corresponding to none, mild, moderate, and severe emphysema, respectively. Yellow circle indicates the extent of emphysema. (A) A 67-year-old man with mild emphysema at baseline LDCT in 2002. Baseline LDCT scan shows vascular splaying, suggesting parenchymal expansion due to emphysema and occasional discrete low-attenuation regions. The participant ultimately died of cardiovascular disease 15.4 years (184.2 months) later. (B) A 69-year-old man with moderate emphysema at baseline LDCT in 2007. The participant died of cardiovascular disease 1.8 years (21.9 months) later. Identifiable low-attenuation regions affected less than half of the lung parenchyma. (C) An 85-year-old woman with severe emphysema at baseline LDCT in 2006. After 5.5 years (65.5 months) of follow-up, the participant died due to chronic obstructive pulmonary disease–related causes. Identifiable low-attenuation regions involved more than half of the lung parenchyma.
Low-dose CT ties emphysema to mortality in previous smokers
September 9, 2025
Related Stories
2009 03 02 17 08 56 389 2009 03 02 Radioactive Symbol
CT
FDA CT overdose probe focuses on Cedars-Sinai
2009 03 02 17 08 56 389 2009 03 02 Radioactive Symbol
CT
FDA issues radiation alert after CT brain perfusion overexposure
2009 10 02 11 32 58 200 Mummy 70
CT
Austrian study uses MDCT to uncover tale of 12 mummies
You think ahead in oncological care.
Sponsor Content
You think ahead in oncological care.
More in CT
General-purpose LLMs can be used to track true critical findings
By Liz Carey
Experts from Stanford and Mayo Clinic Arizona tested few-shot prompting effectiveness with GPT-4 and Mistral-7B.
September 10, 2025
Chatgpt Artificial Intelligence Ai Head n9f Ar0 G2 Ll
RT's MRI, CT exam prep booklets help mitigate children's anxieties
By Kate Madden Yee
Giuseppe Scappatura penned the booklets to help children face the exams with "greater serenity and collaboration."
September 10, 2025
Scappatura Giuseppe Book Covers Thumbnail
Experts propose generalist radiology AI framework
By Liz Carey
A team of researchers outlined five key features of diagnostic generalist radiology AI (GRAI).
September 9, 2025
2025 09 09 Generalist Radiology Ai Six Diagnoses Thumbnail
Low-dose CT ties emphysema to mortality in previous smokers
By Amerigo Allegretto
Study findings highlight the clinical relevance of CT-diagnosed emphysema.
September 9, 2025
Representative axial images of mild, moderate, and severe emphysema at baseline low-dose CT (LDCT). Participants were categorized as having no emphysema or mild, moderate, or severe emphysema. When present, emphysema was mild if no distinct regions of reduced attenuation were visible on the CT scan, but vascular splaying indicates parenchymal expansion, or if only occasional discrete low-attenuation regions were observed. Moderate emphysema was defined by the presence of identifiable low-attenuation regions affecting less than half of the lung parenchyma, whereas severe emphysema was defined by the presence of identifiable low-attenuation regions that involved more than half of the lung parenchyma. A scoring system from 0 to 3 was applied, corresponding to none, mild, moderate, and severe emphysema, respectively. Yellow circle indicates the extent of emphysema. (A) A 67-year-old man with mild emphysema at baseline LDCT in 2002. Baseline LDCT scan shows vascular splaying, suggesting parenchymal expansion due to emphysema and occasional discrete low-attenuation regions. The participant ultimately died of cardiovascular disease 15.4 years (184.2 months) later. (B) A 69-year-old man with moderate emphysema at baseline LDCT in 2007. The participant died of cardiovascular disease 1.8 years (21.9 months) later. Identifiable low-attenuation regions affected less than half of the lung parenchyma. (C) An 85-year-old woman with severe emphysema at baseline LDCT in 2006. After 5.5 years (65.5 months) of follow-up, the participant died due to chronic obstructive pulmonary disease–related causes. Identifiable low-attenuation regions involved more than half of the lung parenchyma.
Siemens highlights early lung cancer diagnosis CT technology at WCLC
By AuntMinnie.com staff writers
The technology, highlighted at the World Conference on Lung Cancer (WCLC), was developed in collaboration with Intuitive.
September 8, 2025
Siemens
ISCT: CT is an ideal imaging modality for cardiometabolic screening
By Kate Madden Yee
Tracking biomarkers on CT could help clinicians better predict patient outcomes.
September 5, 2025
Ct Scanner Control Room2 Radiologist
U.S. FDA clears 4DMedical's ventilation-perfusion CT:VQ imaging system
By AuntMinnie.com staff writers
CT:VQ converts standard, noncontrast chest CTs into quantitative, lobar ventilation, and perfusion maps.
September 5, 2025
Ct Scanner 6563edb5e443e
ISCT: Radiologists can help reduce iodinated contrast media waste
By Amerigo Allegretto
Radiologists can take proactive measures in reducing iodinated contrast media waste, according to an ISCT presentation.
September 5, 2025
Wastewater Treatment
ISCT: Mayo Clinic expert outlines how best to allocate PCCT resources
By Liz Carey
A Mayo Clinic radiologist discusses overcoming photon-counting CT (PCCT) operational challenges.
September 5, 2025
2025 09 05 Isct Temporal Bone Ossicular Impact Pcct Imaging Thumbnail
ISCT: 2022 ICM shortage was a 'wake-up call.' Did we listen?
By Kate Madden Yee
In 2022, the global supply chain for ICM was disrupted by COVID lockdowns -- and this kind of crisis will likely occur again.
September 4, 2025
Contrast Injector
Siemens completes first U.S. install of Naeotom Alpha.Pro
By AuntMinnie.com staff writers
University Hospitals health system in Cleveland is the first U.S. health system to have installed Siemens Healthineers' Naeotom Alpha.Pro system.
September 4, 2025
Naeotom Alpha.Pro
Revealed: The cause of CT safety incident in Belgium
By Edna Astbury-Ward, PhD
A single bottle of contaminated contrast agent was the cause of eight patients' illness after undergoing CT in Belgium.
September 4, 2025
Klebsiella Adobe Zachary
Page 1 of 670
Next Page